XML 111 R96.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock-Based Compensation - Equity Awards Outstanding and Exercisable (Details) - $ / shares
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Stock options        
Options Outstanding        
Options, outstanding at beginning of period (in shares) 1,344,795 1,421,520 1,383,332  
Options, granted (in shares) 85,755 50,000 111,000  
Options, assumed (in shares) 883,733      
Options, exercised (in shares) (271,703) (74,531) (57,464)  
Options, forfeited (in shares) (38,300) (52,194) (15,348)  
Options, outstanding at end of period (in shares) 2,004,280 1,344,795 1,421,520 1,383,332
Options, exercisable (in shares) 1,680,525      
Options, Weighted Average Exercise Price        
Options, weighted average exercise price, beginning of period (in usd per share) $ 11.70 $ 11.02 $ 10.06  
Options, weighted average exercise price, granted (in usd per share) 26.72 27.48 20.18  
Options, weighted average exercise price, assumed (in usd per share) 24.17      
Options, weighted average exercise price, exercised (in usd per share) 19.20 6.83 4.59  
Options, weighted average exercise price, forfeited (in usd per share) 20.51 15.21 14.25  
Options, weighted average exercise price, end of period (in usd per share) 16.66 11.70 11.02 $ 10.06
Options, weighted average exercise price, exercisable (in usd per share) 16.62      
Options, Weighted Average Grant Date Fair Value        
Options, weighted average grant date fair value at beginning of period (in usd per share) 6.04 6.01 5.50  
Options, weighted average grant date fair value, granted (in usd per share) 15.71 14.37 10.13  
Options, weighted average grant date fair value, assumed (in usd per share) 5.71      
Options, weighted average grant date fair value, exercised (in usd per share) 4.85 18.43 11.62  
Options, weighted average grant date fair value, forfeited (in usd per share) 9.80 7.50 6.99  
Options, weighted average grant date fair value at end of period (in usd per share) 6.06 $ 6.04 $ 6.01 $ 5.50
Options, weighted average grant date fair value, exercisable (in usd per share) $ 5.49      
Options, Weighted Average Remaining Term        
Options, outstanding, weighted average remaining term 4 years 6 months 24 days 6 years 10 months 2 days 6 years 11 months 6 days 8 years 3 months 15 days
Options, exercisable, weighted average remaining contractual term 4 years 20 days      
Stock options | Minimum        
Options, Weighted Average Exercise Price        
Options, weighted average exercise price, beginning of period (in usd per share) $ 2.68 $ 2.28 $ 2.28  
Options, weighted average exercise price, granted (in usd per share) 26.63 23.31 16.57  
Options, weighted average exercise price, assumed (in usd per share) 10.94      
Options, weighted average exercise price, exercised (in usd per share) 2.68 2.96 2.96  
Options, weighted average exercise price, forfeited (in usd per share) 12.10 10.53 6.08  
Options, weighted average exercise price, end of period (in usd per share) 2.68 2.68 2.28 $ 2.28
Options, weighted average exercise price, exercisable (in usd per share) 2.68      
Stock options | Maximum        
Options, Weighted Average Exercise Price        
Options, weighted average exercise price, beginning of period (in usd per share) 27.87 23.19 18.07  
Options, weighted average exercise price, granted (in usd per share) 27.47 31.28 23.19  
Options, weighted average exercise price, assumed (in usd per share) 31.88      
Options, weighted average exercise price, exercised (in usd per share) 29.79 17.10 6.08  
Options, weighted average exercise price, forfeited (in usd per share) 27.87 31.28 16.57  
Options, weighted average exercise price, end of period (in usd per share) 31.88 $ 27.87 $ 23.19 $ 18.07
Options, weighted average exercise price, exercisable (in usd per share) $ 31.88      
Stock appreciation rights        
Shares        
Outstanding at beginning of period (in shares) 0 0    
Granted (in shares) 0      
Assumed (in shares) 180,789      
Vested (in shares) (37,186)      
Forfeited (in shares) 0      
Outstanding at end of period (in shares) 143,603 0 0  
Exercisable (in shares) 143,603      
Weighted-Average Exercise Price        
Outstanding at beginning of period (in usd per share) $ 0.00      
Granted (in usd per share) 0.00      
Assumed (in usd per share) 15.61      
Exercised (in usd per share) 15.61      
Forfeited (in usd per share) 0.00      
Outstanding at end of period (in usd per share) 15.61 $ 0.00    
Exercisable (in usd per share) $ 15.61      
Outstanding, Weighted-Average Remaining Term 1 year 9 months 16 days      
Exercisable, Weighted-Average Remaining Term 1 year 9 months 16 days      
Restricted stock units        
Shares        
Outstanding at beginning of period (in shares) 692,823 901,655 883,816  
Granted (in shares) 329,899 175,773 305,714  
Assumed (in shares) 1,088,674      
Vested (in shares) (460,895) (295,600) (219,875)  
Forfeited (in shares) (92,060) (89,005) (68,000)  
Outstanding at end of period (in shares) 1,558,441 692,823 901,655 883,816
Weighted-Average Grant Date Fair Value        
Outstanding at beginning of period (in usd per share) $ 15.23 $ 13.26 $ 11.31  
Granted (in usd per share) 25.72 29.81 14.38  
Assumed (in usd per share) 26.02      
Exercised (in usd per share) 19.47 14.98 11.64  
Forfeited (in usd per share) 27.24 14.94 10.65  
Outstanding at end of period (in usd per share) $ 23.01 $ 15.23 $ 13.26 $ 11.31
Performance-based restricted stock units        
Shares        
Outstanding at beginning of period (in shares) 1,563,951 450,000 0  
Granted (in shares) 537,261 1,114,951 450,000  
Assumed (in shares) 0      
Vested (in shares) (25,424) 0 0  
Forfeited (in shares) (88,728) (1,000) 0  
Outstanding at end of period (in shares) 1,987,060 1,563,951 450,000 0
Weighted-Average Grant Date Fair Value        
Outstanding at beginning of period (in usd per share) $ 20.86 $ 13.26 $ 0.00  
Granted (in usd per share) 24.75 23.19 15.15  
Assumed (in usd per share) 0.00      
Exercised (in usd per share) 31.02 0.00 0.00  
Forfeited (in usd per share) 28.15 27.61 0.00  
Outstanding at end of period (in usd per share) $ 21.47 $ 20.86 $ 13.26 $ 0.00